With the strong recovery of the pharma
is at the pre-virus levels and has been attempting to breakout of the range. The sector has been in consolidation for several days and it may attempt a breakout to slightly higher levels. The pharma
sector may not face sell offs in the midst of the pandemic, in my opinion.